Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.31 (-10.69%)
Bid:
2.60
Ask:
2.91
Spread: 0.31 (11.923%)
Market Cap: £4.73m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Board Changes

18 May 2016 07:00

RNS Number : 5341Y
Nanoco Group PLC
18 May 2016
 

For immediate release

18 May 2016

 

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Board Changes

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that its Chairman, Tony Clinch, has resigned as a director after six years on the Company's Board, a period during which he has led the Company through key corporate milestones including the move from AIM to the Official List and from an exclusive to a non-exclusive commercialisation strategy in the display market.

Tony joined Nanoco's Board as a Non-Executive Director in March 2010 and was appointed Chairman in April 2013.

Chris Richards, who joined Nanoco's Board as a Non-Executive Director in November 2015, has been appointed Chairman.

The above Board changes are taking place with immediate effect.

Michael Edelman, Nanoco's Chief Executive Officer, said: "On behalf of the Board, I would like to express sincere thanks to Tony Clinch for the major contribution he has made to Nanoco's development in the past six years, most recently as Chairman. In this role, he has provided wise counsel on the commercial transition of the Company in the display market, opening up new commercial opportunities through a non-exclusive licensing strategy. We thank Tony for his dedication to Nanoco and wish him well in his future endeavours.

"I would also like to welcome Chris Richards, a Non-Executive Director for the past six months, to the role of Chairman. I'm confident that he will build on the platform that Tony has created, and guide us in the exploitation of Nanoco's world-leading technology through multiple channels in the display market and in our other target markets."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has a non-exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAESXFAEKEAF
Date   Source Headline
23rd May 20144:45 pmRNSHolding(s) in Company
15th May 20142:22 pmRNSHolding(s) in Company
13th May 20147:00 amRNSHolding(s) in Company
7th May 20143:45 pmRNSHolding(s) in Company
2nd May 20146:03 pmRNSHolding(s) in Company
2nd May 20143:37 pmRNSHolding(s) in Company
29th Apr 20142:25 pmRNSHolding(s) in Company
29th Apr 201411:58 amRNSHolding(s) in Company
24th Apr 20147:00 amRNSWelcomes RoHS Report
17th Apr 20143:48 pmRNSHolding(s) in Company
9th Apr 20149:00 amRNSHolding(s) in Company
4th Apr 20141:30 pmRNSHolding(s) in Company
1st Apr 20146:23 pmRNSHolding(s) in Company
28th Mar 201410:45 amRNSHolding(s) in Company
25th Mar 20147:00 amRNSInterim Results
14th Mar 20149:14 amRNSHolding(s) in Company
5th Mar 20149:30 amRNSHolding(s) in Company
28th Feb 20143:10 pmRNSHolding(s) in Company
14th Feb 201412:04 pmRNSHolding(s) in Company
12th Feb 20149:49 amRNSHolding(s) in Company
10th Feb 20149:01 amRNSHolding(s) in Company
7th Feb 20149:44 amRNSHolding(s) in Company
4th Feb 20147:00 amRNSHolding(s) in Company
30th Jan 20147:00 amRNSNotification of Interim Results
27th Jan 201411:45 amRNSHolding(s) in Company
24th Jan 20147:00 amRNSDirector's Dealing
22nd Jan 201412:30 pmRNSHolding(s) in Company
21st Jan 201411:10 amRNSHolding(s) in Company
21st Jan 20148:55 amRNSDirector's Dealing
20th Jan 201410:06 amRNSHolding(s) in Company
18th Dec 201311:15 amRNSResult of AGM
18th Dec 20137:00 amRNSAGM Statement
12th Dec 201311:19 amRNSBlocklisting Interim Review
13th Nov 20138:50 amRNSHolding(s) in Company
12th Nov 20137:00 amRNSPosting of Annual Report & Accounts
5th Nov 201312:09 pmRNSHolding(s) in Company
29th Oct 201311:56 amRNSHolding(s) in Company
21st Oct 20133:45 pmRNSHolding(s) in Company
17th Oct 20134:34 pmRNSHolding(s) in Company
17th Oct 20134:33 pmRNSChange of significant shareholder ownership
17th Oct 20134:33 pmRNSHolding(s) in Company
17th Oct 20134:29 pmRNSHolding(s) in Company
15th Oct 20135:21 pmRNSHolding(s) in Company
15th Oct 20135:14 pmRNSHolding(s) in Company
15th Oct 20134:00 pmRNSCompletion of Placing
15th Oct 201310:53 amRNSPlacing to raise £10m
14th Oct 20137:00 amRNSPreliminary Results
27th Sep 20137:00 amRNSCorporate Update
27th Aug 20137:00 amRNSNotification of Preliminary Results
13th Aug 20131:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.